Sonnet BioTherapeutics Competitors and Similar CompaniesClear all
Sonnet BioTherapeutics's competitors and similar companies include MABION.
 Sonnet BioTherapeutics Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company. |  MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. | |
Founding Date | Founding Date 2011 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Princeton, US HQ | Locations Konstantynów Łódzki, PL HQ |
Employees | Employees 12 | Employees 95 |
Valuation ($) | Valuation ($) 2.9 m | Valuation ($) 21.7 m |
Financial | ||
Revenue (est.) | Revenue (est.) $1m (FY, 2025) | Revenue (est.) zł15.8m (FY, 2025) |
Net income | Net income ($16m) (FY, 2025) | Net income (zł62.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
MABION
HQ
Konstantynów Łódzki, PL
Employees
95
Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
View company